Biomarker Lens

Biomarkers · Chemical

and N-Desmethylflunitrazepam

Understand what and N-Desmethylflunitrazepam signals

Commercial laboratory assays
1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for and N-Desmethylflunitrazepam

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Flunitrazepam and Metabolites Quantitative

Laboratory
Quest Diagnostics
Test code
18964
Specimen
Serum
Fasting
Not required

Laboratory assay overview

In Latin America and Europe, Rohypnol (Flunitrazepam) is prescribed as a short-term treatment for insomnia, and as a preanesthetic medication. Flunitrazepam is considered a drug of abuse when used to enhance the effect of other substances such as marijuana, heroin, and ethanol. The combination of ethanol and flunitrazepam may lead to sedation, loss of motor function, impaired judgement, behavioral changes, and anterograde amnesia.

Quest Diagnostics population reference ranges

Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

PopulationRange
Flunitrazepam<5 ng/mL
7-Aminolunitrazepam<5 ng/mL
N-Desmethylflunitrazepam<5 ng/mL
View complete laboratory reference notes

Flunitrazepam <5 ng/mL 7-Aminolunitrazepam <5 ng/mL N-Desmethylflunitrazepam <5 ng/mL

Quest Diagnostics test directory, test code 18964

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets. Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.